Approval · Notice of Compliance 499 · 2002
PMS-FLUCONAZOLE: Notice of Compliance 499
Issued September 25, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 499
- Date
- September 25, 2002
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antifungal agent
- Canadian reference product
- DIFLUCAN 150 (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-FLUCONAZOLE | 02246620 | Dormant |
Medicinal ingredients
- FLUCONAZOLE 150 MG per CAP